COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Cryolife, Inc.. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jul 15, 2026 to Jul 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MUQ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P010003, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 1655 Roberts Blvd. NW, Kennesaw, GA, 30144. Recorded on P010003/S043, decision dated Jul 15, 2026.
Device categories in this collection
Glue, surgical, arteries.
Changes described in PMA records
FDA’s recorded scope: approval for transferring the 2 mL BioGlue Surgical Adhesive fill from the currently approved 5 mL syringe body to the larger 10 mL syringe body and requested to extend the shelf life from 21 to 24 months for the 2 mL configuration.
Jul 15, 2026 · Real-Time ProcessSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.